Home Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
Article
Licensed
Unlicensed Requires Authentication

Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents

  • Hiba Al-Zubeidi , Carla Demeterco and Kenneth Lee Jones EMAIL logo
Published/Copyright: August 12, 2014

Abstract

Introduction: Periodic paralysis associated with hyperthyroidism and hypokalemia is an uncommon disorder reported primarily in Asian males and rarely in children. We report three Hispanic adolescent males who were seen with Graves’ disease (GD) and THPP.

Methods: The method used was chart review.

Results: Two of these boys presented with episodes of paralysis and were diagnosed with GD. The third was initially seen with hyperthyroidism and developed weakness and paralysis when his disease progressed because of therapeutic noncompliance. Hypokalemia was documented in two of the three patients with the third not seen during paralysis. Intravenous K+ was required in only one case. All three boys were treated with antithyroid medications and β blockers, and the musculoskeletal symptoms resolved in all three when hyperthyroidism was controlled after 2 weeks of treatment. The duration for each episode of weakness and paralysis varied in each case and resolved within 15 min to 2 h in case 1, 1–5 h in case 2, and 24 h in case 3.

Conclusions: THPP is considered uncommon except in Asian males and rare in childhood and adolescence. Its occurrence in these three Hispanic boys suggests that it may occur more frequently in the young and in the USA than has been suspected, especially with the changing national demographics. We believe that our experience should raise the awareness of THPP among pediatric care providers.


Corresponding author: Kenneth Lee Jones, MD, MC5103 3020 Children’s Way, San Diego, CA 92123-4282, USA, Phone: +1-858-966-4032, Fax: +1-858-966-6227, E-mail:

References

1. Bernard JD, Larson MA, Norris FH Jr. Thyrotoxic periodic paralysis in Californians of Mexican and Filipino ancestry. Calif Med 1972;116:70–4.Search in Google Scholar

2. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 1992;71:109–20.10.1097/00005792-199205000-00001Search in Google Scholar

3. McFadzean AJ, Young R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1967;1:451–5.10.1136/bmj.1.5538.451Search in Google Scholar

4. Okinaka S, Shizume K, Lino S, Watanabe A, Irie M, et al. The association of periodic paralysis and hyperthyroidism in Japan. J Clin Endocrinol Metab 1957;17:1454–9.10.1210/jcem-17-12-1454Search in Google Scholar

5. Zumo LA, Terzian C, Brannan T. Thyrotoxic hypokalaemic periodic paralysis in a Hispanic male. J Natl Med Assoc 2002;94:383–6.Search in Google Scholar

6. Salifu MO, Otah K, Carroll HJ, Ifudu O, Friedman EA, et al. Thyrotoxic hypokalaemic paralysis in a Black man. Q J Med 2001;94:659–60.10.1093/qjmed/94.11.659Search in Google Scholar

7. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999;159:601–6.10.1001/archinte.159.6.601Search in Google Scholar

8. Engel AG. Thyroid function and periodic paralysis. Am J Med 1961;30:327–33.10.1016/0002-9343(61)90104-8Search in Google Scholar

9. Kung AW. Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab 2006;91:2490–5.10.1210/jc.2006-0356Search in Google Scholar PubMed

10. Vanderpump MP, Tunbridge WM. The epidemiology of autoimmune thyroid disease. In: Volpé R, editor. Autoimmune endocrinopathies. Vol. 15 of Contemporary Endocrinology. Totowa, NJ: Humana Press, 1999:141–62.Search in Google Scholar

11. Tinker TD, Vannatta JB. Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature. J Okla State Med Assoc 1987;80:76–83.Search in Google Scholar

12. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK, et al. Thyrotoxic periodic paralysis in a Chinese population. Q J Med 1996;89:463–8.10.1093/qjmed/89.6.463Search in Google Scholar PubMed

13. Cheng C-J, Lin S-H, Lo Y-F, Yang S-S, Hsu Y-J, et al. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis. J Biol Chem 2011;286:27426–35.Search in Google Scholar

14. Miller JD, Quillian W, Cleveland WW. Nonfamilial hypokalemic periodic paralysis and thyrotoxicosis in a 16-year-old male. Pediatrics 1997;100:412–3.10.1542/peds.100.3.412Search in Google Scholar PubMed

15. Schalin-Jäntti C, Laine T, Valli-Jaakola K, Lönnqvist T, Kontula K, et al. Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis. Horm Res 2005;63:139–44.10.1159/000084689Search in Google Scholar PubMed

16. Wong GW, Leung TF, Lo AF, Aluja AT, Cheng PS. Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr 2000;159:934–41.10.1007/PL00008375Search in Google Scholar

17. Lapie P, Lory P, Fontine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 1997;7:234–40.10.1016/S0960-8966(97)00435-5Search in Google Scholar

18. Ahlawat SK, Sachdev A. Hypokalemic paralysis. Postgrad Med J 1999;75:193–7.Search in Google Scholar

19. Liu YC, Tsai WS, Chau T, Lin SH. Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis. Am J Med Sci 2004;327:264–7.10.1097/00000441-200405000-00025Search in Google Scholar PubMed

20. Kelley DE, Gharid H, Kennedy FP, Duda RJ, McManis MB. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 1989;149:2597–600.10.1001/archinte.1989.00390110139031Search in Google Scholar

21. Okihiro MM, Nordyke RA. Hypokalemic periodic paralysis: experimental precipitation with sodium liothyronine. J Am Med Assoc 1966;198:949–51.10.1001/jama.1966.03110210199056Search in Google Scholar

22. Dias de Silva MR, Cerutti JM, Tengan CH, Furuzawa GK, Vieira TC, et al. Mutations linked to familial hypokalemic periodic paralysis in the calcium channel _1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin Endocrinol (Oxf) 2002;56:367–75.Search in Google Scholar

23. Ryan DP, Ptácek LJ. Ion channel disorders. In: Rosenberg RN, DiMauro S, Paulson HL, Ptácek LJ, Nestler EJ, editors. The molecular and genetic basis of neurologic and psychiatric disease. Philadelphia: Lippincott Williams & Wilkins, 2007: 550–68.Search in Google Scholar

24. Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2009;140:88–98.10.1016/j.cell.2009.12.024Search in Google Scholar PubMed PubMed Central

25. Khan FA, Baron DN. Ion flux and Na+,K+-ATPase activity of erythrocytes and leucocytes in thyroid disease. Clin Sci 1987;72:171–9.10.1042/cs0720171Search in Google Scholar PubMed

26. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. In vivo and in vitro sodium pump activity in subjects with thyrotoxic periodic paralysis BMJ 1991;303:1096–9.10.1136/bmj.303.6810.1096Search in Google Scholar PubMed PubMed Central

27. Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 2004;22:54454–7.Search in Google Scholar

28. Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 2004;26:157–61.10.1016/j.jemermed.2003.05.004Search in Google Scholar PubMed

29. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 2001;37:620–3.10.1053/ajkd.2001.22090Search in Google Scholar

30. Liu Z, Braverman LE, Malabanan A. Thyrotoxic periodic paralysis in a Hispanic man after the administration of prednisone. Endocr Pract 2006;12:427–31.10.4158/EP.12.4.427Search in Google Scholar PubMed

31. Wongraoprasert S, Buranasupkajorn P, Sridama V, Snabboon T. Thyrotoxic periodic paralysis induced by pulse methylprednisolone. Intern Med 2007;46:1431–3.10.2169/internalmedicine.46.0044Search in Google Scholar PubMed


Article note

The first draft of this manuscript was written by Kenneth Lee Jones. None of the authors received any form of payment for its preparation.


Received: 2014-1-13
Accepted: 2014-7-8
Published Online: 2014-8-12
Published in Print: 2015-1-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Childhood Craniopharyngioma
  3. Selected papers from the 3rd International Multidisciplinary Postgraduate Course, April 24–27, 2014
  4. Childhood craniopharyngioma – current status and recent perspectives in diagnostics and treatment
  5. The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma
  6. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
  7. Endocrine aspects and sequel in patients with craniopharyngioma
  8. Surgery for pediatric craniopharyngiomas: is less more?
  9. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
  10. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
  11. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
  12. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment
  13. Review article
  14. Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls
  15. Images in pediatric endocrinology
  16. Intestinal invagination in diabetic ketoacidosis: case report
  17. Original articles
  18. Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort
  19. The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation
  20. Gender differences and age-related changes in body fat mass in Tibetan children and teenagers: an analysis by the bioelectrical impedance method
  21. A study of genes involved in adipocyte differentiation
  22. Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
  23. The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance
  24. Growth failure associated with early neglect: pilot comparison of neglected US children and international adoptees
  25. Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions
  26. Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys
  27. Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
  28. Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study
  29. Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin
  30. Influence of catch-up growth on abdominal fat distribution in very low birth weight children – cohort study
  31. Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
  32. Pulmonary function in children with type 1 diabetes mellitus
  33. Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification
  34. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial
  35. Vitamin D-containing supplements for children between 1–3 years of age: Are they essential for bone health?
  36. Anti-Mullerian hormone levels in American girls by age and race/ethnicity
  37. The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III
  38. Thyroid disease in Chinese girls with Turner syndrome
  39. Patient reports
  40. Pure gonadal dysgenesis (Swyer syndrome) due to microdeletion in the SRY gene: a case report
  41. Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene
  42. Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
  43. A case of pediatric ectopic thyroid in lateral lymph nodes
  44. Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature
  45. Needle detachment from the Sure-T® infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia
  46. Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0016/html
Scroll to top button